MAPK1 and ischemia: Furthermore, the ischemic damage exacerbation after inhibition of the MAPK/ERK signaling, in our experimental paradigm, is consistent with observations that ischemia/reperfusion-induced ERK phosphorylation can be both beneficial and detrimental by acting through different receptors or pathways [38].